Merger and acquisition activity in the global healthcare sector should continue to rise next year, led by healthcare companies rather than private equity, according to a survey of industry executives.
The report, published today by investment bank Jefferies, surveyed 600 senior leaders in the sector. It found 68% of respondents expected the volume of deals in healthcare to rise in 2024, with 60% believing companies within the sector will dominate the transactions. The volume of M&A deals in the healthcare sector has surged 22% to $341 billion so far this year, according to data provider Dealogic, bucking a decline in M&A activity across most industries, Reuters reports. Read more.